Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiaSorin
Saluggia, Piedmont, Italyus.diasorin.com ↗
- Ownership
- Public · DIA
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
DiaSorin is a global leader in the development and commercialization of specialty immunodiagnostic and molecular diagnostic tests. Its platforms support automated laboratory workflows with a broad menu of assays covering infectious diseases to oncology. The company has expanded through acquisitions such as Biotrin and NorDiag to strengthen its portfolio in parvovirus testing and nucleic acid extraction. It maintains partnerships with major labs like Quest Diagnostics. Its products are widely adopted across North America, Europe, Asia-Pacific regions.
- Therapeutic areas
- OncologyEndocrinologyImmunologyCardiovascularNeurologyInfectious Diseases
- Modalities
- DeviceDiagnostic reagent kit (Immunodiagnostic)Diagnostic reagent kit (Molecular diagnostics)Nucleic acid extraction technologyImmunoassay platform (CLIA, ELISA)Molecular diagnostics platform (LAMP technology)
- Industry
- Molecular Diagnostics
02
Partnerships
Quest Diagnostics (Vitamin D testing)Beckman Coulter (Hepatitis/HIV commercialization in China)Laboratory Corporation of America Holdings ("LabCorp") extension agreement until at least ~2018
03
Financials
- Market cap
- $44.1B
- Enterprise value
- $44.1B
Beyond the preview
Go deeper on DiaSorin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DiaSorin.